Ernexa Therapeutics Inc. (ERNA)
NASDAQ·Healthcare·Biotechnology
$4.02
+16.52%
Mkt Cap $2.34M
No analyst coverage available
We don't have analyst ratings or price target data for Ernexa Therapeutics Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.